Cadence Bank’s Allergan plc AGN Stock Holding History

Cadence Bank’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,897	Closed	-$1.22M	–	197
2020 Q1	$1.22M	Hold	6,897	–	–	0.31%	69
2019 Q4	$1.32M	Sell	6,897 -200	-3%	-$36.1K	0.24%	75
2019 Q3	$1.19M	Hold	7,097	–	–	0.11%	84
2019 Q2	$1.19M	Sell	7,097 -250	-3%	-$34.6K	0.11%	84
2019 Q1	$1.08M	Sell	7,347 -200	-3%	-$29K	0.11%	90
2018 Q4	$1.01M	Sell	7,547 -204	-3%	-$33.4K	0.12%	93
2018 Q3	$1.48M	Hold	7,751	–	–	0.14%	80
2018 Q2	$1.29M	Hold	7,751	–	–	0.12%	87
2018 Q1	$1.3M	Hold	7,751	–	–	0.12%	88
2017 Q4	$1.27M	Buy	+7,751	New	+$1.39M	0.12%	89

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Cadence Bank's AGN Position: Q2 2020 in Review

Cadence Bank sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,897 shares — an estimated $1.22M sold.

Cadence Bank first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $1.48M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Cadence Bank reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Cadence Bank sold 6,897 Allergan plc shares in Q2 2020, an estimated $1.22M.
Cadence Bank first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
Cadence Bank's Allergan plc position peaked at $1.48M in Q3 2018.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cadence Bank's 13F filing for Q2 2020, filed 27 Jul 2020.